Therefore, other drug resistance genes were examined and the ABC-G2 gene was found to be expressed dominantly in CD133+/ESA+ CCSCs, but not in CD133−/ESA+ cancer cells derived from cancer tissue (Fig. 4). The gene discussed is PROM1; the disease is cancer.